HSG's Life Science Portfolio

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

MoleculeMind is an AI-integrated biotech firm that fuses artificial intelligence with biotechnology to form a new development platform.

Neurophth is China's first gene therapy company for ophthalmic diseases.

Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

Focusing on major innovative vaccines with independent intellectual property rights.